Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who have been diagnosed with differentiated thyroid cancer (either papillary or follicular type)
- People who received radioactive iodine (RAI) treatment within the last three years
- People experiencing mild to moderate side effects from radioactive iodine treatment
- People who are able to give informed consent in English
- People who have access to a computer, tablet, or smartphone with an internet connection
Who may not be able to join:
- People whose doctor or a trained study team member has identified a condition that would prevent them from giving informed consent or completing study activities — for example, a cognitive condition, a psychiatric condition, or hearing difficulties
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alaina Carr, PhD, Georgetown University
Phone: 202-687-0958
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility (Retention and Engagement); Acceptability (Quantitative); Acceptability (Qualitative)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.